Millennium Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-60,000
Closed -$1.83M 5863
2024
Q1
$1.83M Sell
60,000
-10,000
-14% -$335K ﹤0.01% 3828
2023
Q4
$2.5M Buy
+70,000
New +$2.6M ﹤0.01% 3421
2023
Q1
Sell
-30,000
Closed -$1.33M 6348
2022
Q4
$1.33M Buy
+30,000
New +$1.25M ﹤0.01% 3892
2021
Q4
Sell
-10,000
Closed -$696K 6759
2021
Q3
$696K Hold
10,000
﹤0.01% 5024
2021
Q2
$793K Hold
10,000
﹤0.01% 4889
2021
Q1
$655K Sell
10,000
-5,000
-33% -$308K ﹤0.01% 4596
2020
Q4
$835K Buy
+15,000
New +$649K ﹤0.01% 3848
2020
Q3
Sell
-5,000
Closed -$225K 4427
2020
Q2
$225K Buy
+5,000
New +$218K ﹤0.01% 3795
2019
Q2
Sell
-20,000
Closed -$536K 4036
2019
Q1
$536K Buy
+20,000
New +$607K ﹤0.01% 3220
2018
Q1
Sell
-20,000
Closed -$365K 3617
2017
Q4
$365K Buy
+20,000
New +$396K ﹤0.01% 3246

Other funds holding ATRC

Millennium Management's ATRC Position: Q1 2026 in Review

Millennium Management increased its AtriCure (ATRC) stake by 9.8% in Q1 2026, buying an estimated $549K and bringing the position to 179,886 shares worth $5.13M. The position accounts for ﹤0.01% of the portfolio, ranked #2907.

Millennium Management first reported a position in ATRC in Q3 2013 and has held it in 48 quarters since. The position peaked at $68.8M in Q4 2021. 223 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.

  • Millennium Management held 179,886 shares of AtriCure worth $5.13M as of Q1 2026.
  • Millennium Management bought 16,091 AtriCure shares in Q1 2026, an estimated $549K.
  • AtriCure made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #2907 holding.
  • Millennium Management first reported a position in AtriCure in Q3 2013 and has held it in 48 quarters since.
  • Millennium Management's AtriCure position peaked at $68.8M in Q4 2021.
  • 223 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.